Randomized Double-Blinded Clinical Trial at Sheba Medical Center: Ivermectin Materially Reduces COVID-19 Viral Shedding

The @CovidAnalysis Ivermectin Meta-Analysis—Probability Ivermectin Not Effective Against COVID-19 One in One Trillion!

A small but important randomized, double-blinded clinical trial sponsored by a top Israeli principal investigator and infectious disease physician embraced the use of ivermectin as a possible candidate to reduce viral shedding as well as lessen clinical deterioration for a targeted 100 early-onset, mild COVID-19 patients. The director of the Center for Geographic & Tropical Medicine at Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv, Professor Eli Schwartz, conducted this clinical trial starting in the summer. TrialSite spoke with Professor Schwartz in November, and he was still enrolling patients; however, he was recently able to conclude the study and report on the results on Vimeo. The study's takeaway: ivermectin significantly reduces the viral shedding overall in patients with COVID-19. Moreover, while the patient sample wasn’t sufficiently sized, the data did reveal that the drug typically used to treat parasites can reduce infectivity duration. Professor Eli Schwartz concludes that more research is needed to capitalize on this promising drug’s potential to significantly impact public health during the pandemic. For example, the drug shows potential to treat ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee